{"id":5900,"date":"2020-02-05T15:06:53","date_gmt":"2020-02-05T20:06:53","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/dangerous-drugs-rights\/"},"modified":"2022-06-21T16:54:48","modified_gmt":"2022-06-21T20:54:48","slug":"droits-drogues-dangereuses","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/fr\/domaines-de-pratique-2\/droits-drogues-dangereuses\/","title":{"rendered":"Drogues dangereuses et vos droits"},"content":{"rendered":"<h2>Vos droits si vous \u00eates bless\u00e9 par un m\u00e9dicament sur ordonnance ou un appareil m\u00e9dical<\/h2>\n<p>Technological advancements in the fields of chemistry, medicine and biology have allowed for the creation of prescription drugs, over-the-counter medications and medical devices that can alleviate pain, eliminate infection and save lives. These products have already enhanced and saved countless lives, but there are some situations where a drug or device may be defective, inadequately tested or simply dangerous. When this occurs, patients can experience serious injuries or may even lose their lives. Even if the drug or device was approved by the Food and Drug Administration (FDA) and is legally on the market, the injured patient may have the right to move forward with a lawsuit against the drug company or device manufacturer.<\/p>\n<p>Prescription and over-the-counter medications are approved by the FDA if they are properly tested and manufactured and offer benefits that outweigh their known risks. Medical devices may be approved on the basis that they are \u201csubstantially equivalent\u201d to devices already approved and on the market for the same use or, for new devices, that they are reasonably effective and safe. In spite of approval requirements, products sometimes still make it to the shelves and into the hands of healthcare professionals when they can cause serious harm. They may also be improperly marketed or mislabeled. Accordingly, there are certain circumstances where the drug company or manufacturer of the medical device may be held liable.<\/p>\n<p>An injured patient may have grounds for a lawsuit if a drug was improperly marketed or labeled, manufactured incorrectly or inadequately tested. The following are basic examples of when a manufacturer may be held liable for injuries caused by one of their drugs or devices:<\/p>\n<ul>\n<li>Le fabricant a obtenu l&#039;approbation de la FDA sur la base de r\u00e9sultats de tests falsifi\u00e9s.<\/li>\n<li>La demande d&#039;approbation du fabricant aupr\u00e8s de la FDA manquait de r\u00e9sultats de test pertinents qui montraient des effets ind\u00e9sirables.<\/li>\n<li>Le m\u00e9dicament faisait partie d&#039;un lot fabriqu\u00e9 dans une installation sp\u00e9cifique o\u00f9 la mauvaise formule a \u00e9t\u00e9 utilis\u00e9e ou le dosage a \u00e9t\u00e9 mal \u00e9tiquet\u00e9.<\/li>\n<li>Le dispositif m\u00e9dical pr\u00e9sentait un d\u00e9faut de fabrication qui le rendait dangereux ou inefficace.<\/li>\n<li>Le dispositif m\u00e9dical pr\u00e9sentait un d\u00e9faut de conception qui impactait son efficacit\u00e9.<\/li>\n<li>Le fabricant a obtenu l&#039;approbation de la FDA sur la base d&#039;une demande 510(k) pour un dispositif m\u00e9dical qui n&#039;\u00e9tait pas r\u00e9ellement \u00e9quivalent \u00e0 un dispositif d\u00e9j\u00e0 approuv\u00e9.<\/li>\n<li>Le fabricant a commercialis\u00e9 un appareil ou un m\u00e9dicament pour un usage autre que celui pour lequel il a \u00e9t\u00e9 approuv\u00e9.<\/li>\n<li>Les publicit\u00e9s du fabricant pour le m\u00e9dicament \u00e9taient trompeuses ou fournissaient des informations incompl\u00e8tes aux patients potentiels.<\/li>\n<\/ul>\n<p>Qu&#039;il s&#039;agisse du produit lui-m\u00eame ou de la mani\u00e8re dont il est \u00e9tiquet\u00e9 ou commercialis\u00e9, il est important d&#039;\u00e9tablir comment le fabricant doit \u00eatre tenu responsable. Dans certaines circonstances, le fabricant peut \u00eatre tenu strictement responsable des blessures d&#039;un patient, ce qui signifie que le patient n&#039;a pas \u00e0 prouver la faute ou l&#039;acte r\u00e9pr\u00e9hensible de la part du fabricant, mais seulement que l&#039;appareil ou le m\u00e9dicament \u00e9tait d\u00e9fectueux et que le patient l&#039;a utilis\u00e9 et s&#039;est bless\u00e9 . Cela peut s&#039;appliquer dans les cas o\u00f9 le m\u00e9dicament ou le dispositif pr\u00e9sentait un d\u00e9faut inh\u00e9rent de conception ou de fabrication. Si l&#039;\u00e9tiquette d&#039;avertissement ou les instructions d&#039;utilisation \u00e9taient inad\u00e9quates ou fausses, cela peut \u00e9galement constituer un motif de <a href=\"\/fr\/domaines-de-pratique-2\/contentieux-pharmaceutique\/\">contentieux pharmaceutique<\/a> fond\u00e9 sur la responsabilit\u00e9 stricte.<\/p>\n<h3>Demander une indemnisation<\/h3>\n<p>Les blessures caus\u00e9es par un m\u00e9dicament dangereux ou un dispositif m\u00e9dical d\u00e9fectueux peuvent avoir un impact profond sur la vie d&#039;un patient. R\u00e9cup\u00e9rer une compensation financi\u00e8re peut aider le patient \u00e0 reconstruire et \u00e0 r\u00e9cup\u00e9rer ce qu&#039;il a perdu. Une indemnisation peut \u00eatre accord\u00e9e pour les soins m\u00e9dicaux, les d\u00e9penses m\u00e9dicales futures, la perte de salaire, la perte de revenus potentiels, les traumatismes \u00e9motionnels, la douleur et la souffrance et \u00e9ventuellement des dommages-int\u00e9r\u00eats punitifs. Parce que chaque cas est diff\u00e9rent, nous vous recommandons de parler \u00e0 un avocat qui est qualifi\u00e9 pour g\u00e9rer ces poursuites dans votre r\u00e9gion. Contactez Napoli Shkolnik PLLC d\u00e8s aujourd&#039;hui.<\/p>","protected":false},"excerpt":{"rendered":"<p>Vos droits en cas de blessure par un m\u00e9dicament sur ordonnance ou un dispositif m\u00e9dical Les progr\u00e8s technologiques dans les domaines de la chimie, de la m\u00e9decine et de la biologie ont permis la cr\u00e9ation de m\u00e9dicaments sur ordonnance, en vente libre\u2026<\/p>","protected":false},"featured_media":0,"menu_order":16,"template":"","practiceareas_category":[743],"class_list":["post-5900","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5900\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/media?parent=5900"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas_category?post=5900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}